# Atypical Presentation of Diffuse Large B-Cell Lymphoma of the Caecum in a Young Patient: A Case Report

**Authors:** Amalan Thuraisingam, Kumail Jaffry, Brigitte Papa

PMC · DOI: 10.7759/cureus.86150 · Cureus · 2025-06-16

## TL;DR

A young woman presented with rare caecal diffuse large B-cell lymphoma, highlighting the need for early diagnosis and multidisciplinary care.

## Contribution

This case report presents a rare atypical presentation of primary caecal DLBCL in a young patient.

## Key findings

- DLBCL of the caecum is rare and often misdiagnosed due to non-specific symptoms.
- PET imaging and histopathology were critical in confirming the diagnosis.
- Multidisciplinary management with R-CHOP chemotherapy improved patient outcomes.

## Abstract

Primary diffuse large B-cell lymphoma (DLBCL) of the colon, particularly involving the caecum, is rare and often poses a diagnostic challenge due to its non-specific presentation and the low incidence of colorectal involvement. Early recognition is crucial, as timely diagnosis and multidisciplinary management can significantly improve patient outcomes. A 29-year-old female presented with a two-week history of intermittent lower abdominal pain, progressive abdominal bloating, weight loss, night sweats, and bilateral ankle swelling over the last four weeks. Initial ultrasonography revealed a large soft tissue mass within the abdomen, initially reported as an ovarian mass; however, further evaluation, including CT imaging and colonoscopy, revealed an ulcerated, partially obstructing caecal mass. Histopathological examination of endoscopic biopsies confirmed DLBCL, non-germinal-centre B-cell subtype. PET imaging revealed multiple large, intensely fluorodeoxyglucose (FDG)-avid lymph nodes below the diaphragm forming a bulky nodal mass, along with a similarly FDG-avid caecal mass, strongly suggesting extra-nodal lymphoma involvement. The patient was subsequently managed with R-CHOP (rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone) chemotherapy under the guidance of a multidisciplinary team. Primary colonic DLBCL is rare, accounting for a small fraction of colorectal malignancies. Its non-specific symptoms, including abdominal pain, altered bowel habits, and constitutional complaints, can mimic more common gastrointestinal conditions. This case highlights the importance of maintaining a broad differential diagnosis, especially in younger patients. While imaging modalities, endoscopic assessment, and histopathology are critical for accurate diagnosis, prompt oncologic consultation and chemotherapy remain central to management. A multidisciplinary treatment approach is vital in improving patient prognosis.

## Linked entities

- **Chemicals:** cyclophosphamide (PubChem CID 2907), doxorubicin hydrochloride (PubChem CID 443939), vincristine sulfate (PubChem CID 249332), prednisone (PubChem CID 5865)
- **Diseases:** diffuse large B-cell lymphoma (MONDO:0018905), DLBCL (MONDO:0018905), lymphoma (MONDO:0003659)

## Full-text entities

- **Diseases:** nodal lymphoma (MESH:D008223), weight loss (MESH:D015431), abdominal pain (MESH:D015746), abdominal bloating (MESH:D000007), colorectal malignancies (MESH:D015179), ovarian mass (MESH:D010049), ankle swelling (MESH:D016512), gastrointestinal conditions (MESH:D005767), DLBCL (MESH:D016403)
- **Chemicals:** FDG (MESH:D019788), prednisone (MESH:D011241), R-CHOP (-), hydroxydaunorubicin (MESH:D004317), rituximab (MESH:D000069283), , vincristine sulfate (MESH:D014750)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12266697/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12266697/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12266697/full.md

---
Source: https://tomesphere.com/paper/PMC12266697